Live
One Link Live rooms, co-hosting, captions, gifts and community tools.

OneLinkUS
GHOST OMNI DIVINE IS GOD LLC
OneLinkUS.com
Sign in with an existing subscription to unlock visual layouts.
Browse worldwide headlines, search any country or region, and choose a topic. Publisher photographs and video appear when available from the news source.
Explore news by country, topic and format →Headlines from publishers around the world. Search any country, region or topic.
No headlines found. Try a broader topic.
More world news →9 results for “United States Trends in the development of cellular and gene therapy in China - Nature live news”
Showing OneLink and reference results. Broader web, photo and video coverage is awaiting the search provider connection.
One Link Live rooms, co-hosting, captions, gifts and community tools.
Worldwide problem-solving, official services, emergency guidance and reliable next steps.
Advanced platform connections, AI, backend and service status.
Gene therapy is medical technology that aims to produce a therapeutic effect through the manipulation of gene expression or through altering the biological properties of living cells. The first attempt at modifying human DNA was performed in 1980, by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989.
Retinitis pigmentosa (RP) is a member of a group of genetic disorders called inherited retinal dystrophy (IRD) that cause loss of vision. Symptoms include trouble seeing at night and decreasing peripheral vision (side and upper or lower visual field).
Genome editing, or genome engineering, or gene editing, is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. Unlike early genetic engineering techniques that randomly insert genetic material into a host genome, genome editing targets the insertions to site-specific locations.
The He Jiankui affair is a scientific and bioethical controversy concerning the use of genome editing following its first use on humans by Chinese scientist He Jiankui, who edited the genomes of human embryos in 2018. He became widely known on 26 November 2018 after he announced that he had created the first human genetically edited babies.
CRISPR gene editing (; (an abbreviation for "clustered regularly interspaced short palindromic repeats") is a genetic engineering technique in molecular biology by which the genomes of living organisms may be modified. It is based on a simplified version of the bacterial CRISPR-Cas9 antiviral defense system.
This article lists notable scientific events and developments that occurred in 2026.